During the past decade, Dawson Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dawson Clinical Research" #1 collaborator was "TIMI Study Group" with 1 trials as a collaborator and "Veristat, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dawson Clinical Research" are "COVID-19" (3 trials), "Diabetes Mellitus" (1 trials), "Dyslipidemias" (1 trials), "Hyperlipidemias" (1 trials) and "Hyperlipoproteinemias" (1 trials). Many other conditions were trialed in "Dawson Clinical Research" in a lesser frequency.

Most popular intervention types in "Dawson Clinical Research" are "Drug" (6 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "ATB-346 low dose" (1 trials) and "ATB-346 mid-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dawson Clinical Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Dawson Clinical Research". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dawson Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dawson Clinical Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".